

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 7.38380952 |
| 2 | skeletal muscle adaptation (GO:0043501) | 6.10748830 |
| 3 | striated muscle atrophy (GO:0014891) | 5.78899299 |
| 4 | negative regulation of muscle hypertrophy (GO:0014741) | 5.64766966 |
| 5 | muscle atrophy (GO:0014889) | 5.33744087 |
| 6 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.00889158 |
| 7 | skeletal muscle tissue regeneration (GO:0043403) | 4.75406795 |
| 8 | muscle filament sliding (GO:0030049) | 4.74649641 |
| 9 | actin-myosin filament sliding (GO:0033275) | 4.74649641 |
| 10 | regulation of centriole replication (GO:0046599) | 4.64507619 |
| 11 | protein deneddylation (GO:0000338) | 4.42313743 |
| 12 | ganglion development (GO:0061548) | 4.38587554 |
| 13 | response to muscle activity (GO:0014850) | 4.36470206 |
| 14 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.19256680 |
| 15 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.11991470 |
| 16 | response to interferon-beta (GO:0035456) | 4.11656099 |
| 17 | cullin deneddylation (GO:0010388) | 4.08663175 |
| 18 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 4.03013575 |
| 19 | platelet dense granule organization (GO:0060155) | 3.95555082 |
| 20 | protein K6-linked ubiquitination (GO:0085020) | 3.88445201 |
| 21 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.85955064 |
| 22 | proteasome assembly (GO:0043248) | 3.81867048 |
| 23 | actin-mediated cell contraction (GO:0070252) | 3.76211437 |
| 24 | heart field specification (GO:0003128) | 3.75970121 |
| 25 | secondary heart field specification (GO:0003139) | 3.75970121 |
| 26 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.73870189 |
| 27 | DNA deamination (GO:0045006) | 3.71002284 |
| 28 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.57027773 |
| 29 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.57027773 |
| 30 | extracellular fibril organization (GO:0043206) | 3.56232837 |
| 31 | protein polyglutamylation (GO:0018095) | 3.52886311 |
| 32 | protein maturation by protein folding (GO:0022417) | 3.46063352 |
| 33 | pseudouridine synthesis (GO:0001522) | 3.45814382 |
| 34 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.44484707 |
| 35 | cellular response to interferon-beta (GO:0035458) | 3.41565865 |
| 36 | response to testosterone (GO:0033574) | 3.40535561 |
| 37 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.33125976 |
| 38 | regulation of DNA endoreduplication (GO:0032875) | 3.28485003 |
| 39 | mesenchymal cell proliferation (GO:0010463) | 3.27592920 |
| 40 | cellular zinc ion homeostasis (GO:0006882) | 3.22857817 |
| 41 | kinetochore assembly (GO:0051382) | 3.21663366 |
| 42 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.21637762 |
| 43 | mesonephros development (GO:0001823) | 3.19121331 |
| 44 | positive regulation of actin filament depolymerization (GO:0030836) | 3.18108553 |
| 45 | morphogenesis of an endothelium (GO:0003159) | 3.18100694 |
| 46 | endothelial tube morphogenesis (GO:0061154) | 3.18100694 |
| 47 | maturation of 5.8S rRNA (GO:0000460) | 3.15273254 |
| 48 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.14816486 |
| 49 | regulation of gene expression by genetic imprinting (GO:0006349) | 3.13164775 |
| 50 | lung secretory cell differentiation (GO:0061140) | 3.08217268 |
| 51 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.07773763 |
| 52 | cartilage morphogenesis (GO:0060536) | 3.07146612 |
| 53 | retina homeostasis (GO:0001895) | 3.01964288 |
| 54 | growth hormone secretion (GO:0030252) | 2.99915069 |
| 55 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.97731090 |
| 56 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.93262561 |
| 57 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.91597227 |
| 58 | mitotic nuclear envelope reassembly (GO:0007084) | 2.91148054 |
| 59 | nuclear envelope reassembly (GO:0031468) | 2.91148054 |
| 60 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.90596055 |
| 61 | lung morphogenesis (GO:0060425) | 2.89811944 |
| 62 | mitochondrion distribution (GO:0048311) | 2.87432451 |
| 63 | embryonic hindlimb morphogenesis (GO:0035116) | 2.84958249 |
| 64 | cellular response to dexamethasone stimulus (GO:0071549) | 2.84330685 |
| 65 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.83573260 |
| 66 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.83512789 |
| 67 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.82827171 |
| 68 | cellular response to exogenous dsRNA (GO:0071360) | 2.80787351 |
| 69 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.80526952 |
| 70 | regulation of glomerulus development (GO:0090192) | 2.78329461 |
| 71 | negative regulation of striated muscle tissue development (GO:0045843) | 2.76101052 |
| 72 | response to activity (GO:0014823) | 2.75469252 |
| 73 | negative regulation of muscle tissue development (GO:1901862) | 2.71844682 |
| 74 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.71632079 |
| 75 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.71632079 |
| 76 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.70625158 |
| 77 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.70625158 |
| 78 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.68603277 |
| 79 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.68480905 |
| 80 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.68480905 |
| 81 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.68480905 |
| 82 | striated muscle adaptation (GO:0014888) | 2.68444841 |
| 83 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.67619140 |
| 84 | regulation of relaxation of muscle (GO:1901077) | 2.66700676 |
| 85 | regulation of transcription involved in cell fate commitment (GO:0060850) | 2.65976703 |
| 86 | protein heterotetramerization (GO:0051290) | 2.65244878 |
| 87 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.65223177 |
| 88 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.64998845 |
| 89 | negative regulation of ligase activity (GO:0051352) | 2.64998845 |
| 90 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.62390023 |
| 91 | regulation of timing of cell differentiation (GO:0048505) | 2.62310990 |
| 92 | xenobiotic catabolic process (GO:0042178) | 2.61848243 |
| 93 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.61228565 |
| 94 | cranial suture morphogenesis (GO:0060363) | 2.60517210 |
| 95 | response to folic acid (GO:0051593) | 2.58797407 |
| 96 | interferon-gamma secretion (GO:0072643) | 2.57802239 |
| 97 | auditory behavior (GO:0031223) | 2.56950750 |
| 98 | protein complex biogenesis (GO:0070271) | 2.55445394 |
| 99 | response to dexamethasone (GO:0071548) | 2.55260225 |
| 100 | response to gravity (GO:0009629) | 10.0780407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 6.15677401 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 5.00167167 |
| 3 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 3.90871790 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.67942621 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.57015997 |
| 6 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.39738213 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.17194705 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.15755994 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.05346327 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.03558701 |
| 11 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.85459798 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.62211852 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.53500823 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.31822449 |
| 15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.30550894 |
| 16 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.23937477 |
| 17 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18711223 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.17109378 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.14729969 |
| 20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.13613219 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.02033310 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.01723567 |
| 23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.00066663 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.99122334 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97104312 |
| 26 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.96685078 |
| 27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.96203319 |
| 28 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.93357233 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.91526953 |
| 30 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.90742517 |
| 31 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.81234770 |
| 32 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.71632180 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.68202522 |
| 34 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.66876778 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.65068277 |
| 36 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.64925897 |
| 37 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.64737821 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.62272371 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.59023342 |
| 40 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.56284835 |
| 41 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.55423517 |
| 42 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.54634390 |
| 43 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.52676223 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.45825331 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45724912 |
| 46 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45562774 |
| 47 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44870128 |
| 48 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43582794 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.41781256 |
| 50 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.41766785 |
| 51 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.41349464 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41243159 |
| 53 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.36103703 |
| 54 | CBP_21632823_ChIP-Seq_H3396_Human | 1.35768029 |
| 55 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35575944 |
| 56 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.34412497 |
| 57 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.32879107 |
| 58 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.31788534 |
| 59 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.28882260 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25431039 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22657861 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21270213 |
| 63 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19613538 |
| 64 | CJUN_26792858_Chip-Seq_BT549_Human | 1.19189821 |
| 65 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.17665002 |
| 66 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16935305 |
| 67 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.14782834 |
| 68 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10612258 |
| 69 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08366045 |
| 70 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07111071 |
| 71 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.06786937 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03623528 |
| 73 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03400335 |
| 74 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03400335 |
| 75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.01967050 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97680312 |
| 77 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.97330484 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96978393 |
| 79 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.95213432 |
| 80 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91894741 |
| 81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.91824478 |
| 82 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.91335500 |
| 83 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.90831228 |
| 84 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.90567287 |
| 85 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.90506623 |
| 86 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90153704 |
| 87 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.88869032 |
| 88 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.87303090 |
| 89 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.86878055 |
| 90 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.83887939 |
| 91 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83750316 |
| 92 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.83026464 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.81887987 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81799539 |
| 95 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.80512318 |
| 96 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.80028368 |
| 97 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.79106383 |
| 98 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.78617170 |
| 99 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.78343251 |
| 100 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.77112053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003950_abnormal_plasma_membrane | 4.54126268 |
| 2 | MP0000751_myopathy | 4.27290755 |
| 3 | MP0000747_muscle_weakness | 3.93831386 |
| 4 | MP0000749_muscle_degeneration | 3.04229152 |
| 5 | MP0003646_muscle_fatigue | 2.89999111 |
| 6 | MP0002089_abnormal_postnatal_growth/wei | 2.65508190 |
| 7 | MP0000750_abnormal_muscle_regeneration | 2.53048008 |
| 8 | MP0002822_catalepsy | 2.51515851 |
| 9 | MP0003123_paternal_imprinting | 2.45079677 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 2.41970543 |
| 11 | MP0002269_muscular_atrophy | 2.41839507 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.41679163 |
| 13 | MP0002095_abnormal_skin_pigmentation | 2.29366241 |
| 14 | MP0000759_abnormal_skeletal_muscle | 2.29153077 |
| 15 | MP0000372_irregular_coat_pigmentation | 2.22453658 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.15042716 |
| 17 | MP0008789_abnormal_olfactory_epithelium | 2.08879467 |
| 18 | MP0000427_abnormal_hair_cycle | 1.99675757 |
| 19 | MP0008775_abnormal_heart_ventricle | 1.97287208 |
| 20 | MP0002106_abnormal_muscle_physiology | 1.93787738 |
| 21 | MP0001968_abnormal_touch/_nociception | 1.71279203 |
| 22 | MP0004147_increased_porphyrin_level | 1.69859388 |
| 23 | MP0010030_abnormal_orbit_morphology | 1.69404809 |
| 24 | MP0000733_abnormal_muscle_development | 1.54361536 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.53922892 |
| 26 | MP0000569_abnormal_digit_pigmentation | 1.46779440 |
| 27 | MP0004885_abnormal_endolymph | 1.46710392 |
| 28 | MP0005620_abnormal_muscle_contractility | 1.46709857 |
| 29 | MP0006072_abnormal_retinal_apoptosis | 1.46368252 |
| 30 | MP0005083_abnormal_biliary_tract | 1.45335835 |
| 31 | MP0005369_muscle_phenotype | 1.43586634 |
| 32 | MP0002177_abnormal_outer_ear | 1.42814305 |
| 33 | MP0003937_abnormal_limbs/digits/tail_de | 1.41250322 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.36041340 |
| 35 | MP0002295_abnormal_pulmonary_circulatio | 1.35404494 |
| 36 | MP0001879_abnormal_lymphatic_vessel | 1.34871113 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.30872051 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.30743561 |
| 39 | MP0004087_abnormal_muscle_fiber | 1.30122038 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.29693716 |
| 41 | MP0002736_abnormal_nociception_after | 1.28105283 |
| 42 | MP0009745_abnormal_behavioral_response | 1.26171099 |
| 43 | MP0000383_abnormal_hair_follicle | 1.26090811 |
| 44 | MP0003942_abnormal_urinary_system | 1.25451928 |
| 45 | MP0004134_abnormal_chest_morphology | 1.21855744 |
| 46 | MP0010678_abnormal_skin_adnexa | 1.21577785 |
| 47 | MP0001299_abnormal_eye_distance/ | 1.19663845 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.18139156 |
| 49 | MP0000049_abnormal_middle_ear | 1.14870549 |
| 50 | MP0000647_abnormal_sebaceous_gland | 1.14292185 |
| 51 | MP0003718_maternal_effect | 1.14089073 |
| 52 | MP0004142_abnormal_muscle_tone | 1.13813369 |
| 53 | MP0003111_abnormal_nucleus_morphology | 1.12642524 |
| 54 | MP0001542_abnormal_bone_strength | 1.09477418 |
| 55 | MP0001529_abnormal_vocalization | 1.06431073 |
| 56 | MP0001905_abnormal_dopamine_level | 1.03606602 |
| 57 | MP0002108_abnormal_muscle_morphology | 1.02304153 |
| 58 | MP0003786_premature_aging | 1.01862636 |
| 59 | MP0004133_heterotaxia | 1.01414133 |
| 60 | MP0001243_abnormal_dermal_layer | 0.99080484 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 0.98239686 |
| 62 | MP0005171_absent_coat_pigmentation | 0.96074213 |
| 63 | MP0000613_abnormal_salivary_gland | 0.95110431 |
| 64 | MP0000534_abnormal_ureter_morphology | 0.94895807 |
| 65 | MP0003077_abnormal_cell_cycle | 0.92904289 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 0.86007588 |
| 67 | MP0004270_analgesia | 0.85880654 |
| 68 | MP0005165_increased_susceptibility_to | 0.85710465 |
| 69 | MP0002282_abnormal_trachea_morphology | 0.84289725 |
| 70 | MP0000762_abnormal_tongue_morphology | 0.84001042 |
| 71 | MP0005197_abnormal_uvea_morphology | 0.82514065 |
| 72 | MP0002075_abnormal_coat/hair_pigmentati | 0.82266104 |
| 73 | MP0002735_abnormal_chemical_nociception | 0.80971831 |
| 74 | MP0002733_abnormal_thermal_nociception | 0.79588375 |
| 75 | MP0002896_abnormal_bone_mineralization | 0.79348395 |
| 76 | MP0009250_abnormal_appendicular_skeleto | 0.77651661 |
| 77 | MP0010094_abnormal_chromosome_stability | 0.75492658 |
| 78 | MP0002233_abnormal_nose_morphology | 0.74939914 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 0.74806648 |
| 80 | MP0005646_abnormal_pituitary_gland | 0.74149898 |
| 81 | MP0008770_decreased_survivor_rate | 0.72553577 |
| 82 | MP0002734_abnormal_mechanical_nocicepti | 0.70896789 |
| 83 | MP0003385_abnormal_body_wall | 0.70421006 |
| 84 | MP0000537_abnormal_urethra_morphology | 0.70029610 |
| 85 | MP0003959_abnormal_lean_body | 0.69475171 |
| 86 | MP0002138_abnormal_hepatobiliary_system | 0.68508467 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 0.66623882 |
| 88 | MP0004484_altered_response_of | 0.65367427 |
| 89 | MP0005499_abnormal_olfactory_system | 0.64178129 |
| 90 | MP0005394_taste/olfaction_phenotype | 0.64178129 |
| 91 | MP0003119_abnormal_digestive_system | 0.62003170 |
| 92 | MP0003755_abnormal_palate_morphology | 0.61966110 |
| 93 | MP0002938_white_spotting | 0.61936992 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.61852863 |
| 95 | MP0001340_abnormal_eyelid_morphology | 0.61268883 |
| 96 | MP0006054_spinal_hemorrhage | 0.59546932 |
| 97 | MP0002184_abnormal_innervation | 0.59416054 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 0.59200014 |
| 99 | MP0002751_abnormal_autonomic_nervous | 0.57608850 |
| 100 | MP0005253_abnormal_eye_physiology | 0.55343722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palpebral edema (HP:0100540) | 5.54354576 |
| 2 | Fibular aplasia (HP:0002990) | 5.03010045 |
| 3 | Mask-like facies (HP:0000298) | 4.98539180 |
| 4 | Aplasia involving bones of the extremities (HP:0009825) | 4.19531910 |
| 5 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.19531910 |
| 6 | Aplasia of the phalanges of the hand (HP:0009802) | 4.19531910 |
| 7 | Ulnar deviation of the wrist (HP:0003049) | 3.75207045 |
| 8 | Conjunctival hamartoma (HP:0100780) | 3.68101317 |
| 9 | Absent phalangeal crease (HP:0006109) | 3.62100199 |
| 10 | Nemaline bodies (HP:0003798) | 3.54808011 |
| 11 | Short tibia (HP:0005736) | 3.52926914 |
| 12 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.38052053 |
| 13 | Adrenal hypoplasia (HP:0000835) | 3.23782012 |
| 14 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.16544531 |
| 15 | Microglossia (HP:0000171) | 3.10086807 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.08045250 |
| 17 | Glucose intolerance (HP:0000833) | 2.97393905 |
| 18 | Severe muscular hypotonia (HP:0006829) | 2.96134666 |
| 19 | Round ear (HP:0100830) | 2.93573315 |
| 20 | Abnormal finger flexion creases (HP:0006143) | 2.91133089 |
| 21 | Distal arthrogryposis (HP:0005684) | 2.88366871 |
| 22 | Delayed CNS myelination (HP:0002188) | 2.87345974 |
| 23 | Deformed tarsal bones (HP:0008119) | 2.79625941 |
| 24 | Abnormal gallbladder physiology (HP:0012438) | 2.78491091 |
| 25 | Cholecystitis (HP:0001082) | 2.78491091 |
| 26 | Muscle fiber inclusion bodies (HP:0100299) | 2.75982792 |
| 27 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.75968870 |
| 28 | Calcaneovalgus deformity (HP:0001848) | 2.75069972 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.75054966 |
| 30 | Absent speech (HP:0001344) | 2.74000698 |
| 31 | Hyperkalemia (HP:0002153) | 2.68630848 |
| 32 | Hepatocellular necrosis (HP:0001404) | 2.66816713 |
| 33 | Secondary amenorrhea (HP:0000869) | 2.53735186 |
| 34 | IgG deficiency (HP:0004315) | 2.44605131 |
| 35 | Mesomelia (HP:0003027) | 2.44231097 |
| 36 | Abnormality of the pons (HP:0007361) | 2.37403869 |
| 37 | Paralysis (HP:0003470) | 2.37074460 |
| 38 | IgM deficiency (HP:0002850) | 2.32930341 |
| 39 | Entropion (HP:0000621) | 2.32614488 |
| 40 | Hepatic necrosis (HP:0002605) | 2.27804681 |
| 41 | Myopathic facies (HP:0002058) | 2.24968134 |
| 42 | Progressive microcephaly (HP:0000253) | 2.21849642 |
| 43 | 3-Methylglutaconic aciduria (HP:0003535) | 2.21033001 |
| 44 | Neck muscle weakness (HP:0000467) | 2.20237681 |
| 45 | Type 2 muscle fiber atrophy (HP:0003554) | 2.17988118 |
| 46 | Hamartoma of the eye (HP:0010568) | 2.17671239 |
| 47 | Down-sloping shoulders (HP:0200021) | 2.16597052 |
| 48 | Submucous cleft hard palate (HP:0000176) | 2.13008015 |
| 49 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.12054125 |
| 50 | Absent hand (HP:0004050) | 2.10961858 |
| 51 | Periorbital edema (HP:0100539) | 2.10749774 |
| 52 | Short 4th metacarpal (HP:0010044) | 2.10455319 |
| 53 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.10455319 |
| 54 | Facial edema (HP:0000282) | 2.07771788 |
| 55 | Cavernous hemangioma (HP:0001048) | 2.06896370 |
| 56 | Amyloidosis (HP:0011034) | 2.06699886 |
| 57 | Action tremor (HP:0002345) | 2.06587417 |
| 58 | Abnormality of the columella (HP:0009929) | 2.06371063 |
| 59 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.03147601 |
| 60 | 2-3 toe syndactyly (HP:0004691) | 2.02718666 |
| 61 | Lower limb amyotrophy (HP:0007210) | 2.00803173 |
| 62 | Mitochondrial inheritance (HP:0001427) | 1.98520799 |
| 63 | Muscle fiber atrophy (HP:0100295) | 1.95054197 |
| 64 | Decreased circulating renin level (HP:0003351) | 1.94636186 |
| 65 | Increased CSF lactate (HP:0002490) | 1.93224345 |
| 66 | Cerebral hypomyelination (HP:0006808) | 1.92876494 |
| 67 | Hypokinesia (HP:0002375) | 1.91726634 |
| 68 | Emotional lability (HP:0000712) | 1.90190452 |
| 69 | Acute necrotizing encephalopathy (HP:0006965) | 1.89335523 |
| 70 | Opisthotonus (HP:0002179) | 1.88744167 |
| 71 | Abnormal glucose tolerance (HP:0001952) | 1.85875161 |
| 72 | Hypoplasia of the uterus (HP:0000013) | 1.85484129 |
| 73 | Toxemia of pregnancy (HP:0100603) | 1.85349624 |
| 74 | Furrowed tongue (HP:0000221) | 1.82668042 |
| 75 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.78734757 |
| 76 | Hypoplastic pelvis (HP:0008839) | 1.77746261 |
| 77 | Increased serum lactate (HP:0002151) | 1.77107661 |
| 78 | True hermaphroditism (HP:0010459) | 1.74695306 |
| 79 | Neonatal respiratory distress (HP:0002643) | 1.73441517 |
| 80 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.73368797 |
| 81 | Decreased subcutaneous fat (HP:0001002) | 1.72584232 |
| 82 | Bone cyst (HP:0012062) | 1.72042410 |
| 83 | Short femoral neck (HP:0100864) | 1.71954372 |
| 84 | Myoglobinuria (HP:0002913) | 1.70981720 |
| 85 | Increased connective tissue (HP:0009025) | 1.70318958 |
| 86 | Myotonia (HP:0002486) | 1.70019841 |
| 87 | Intellectual disability, moderate (HP:0002342) | 1.69742996 |
| 88 | Preaxial hand polydactyly (HP:0001177) | 1.69677933 |
| 89 | Asplenia (HP:0001746) | 1.67483264 |
| 90 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.67191563 |
| 91 | Absent septum pellucidum (HP:0001331) | 1.66717578 |
| 92 | Type 1 muscle fiber predominance (HP:0003803) | 1.66613284 |
| 93 | Fatigue (HP:0012378) | 1.65548918 |
| 94 | Neuroendocrine neoplasm (HP:0100634) | 1.65203521 |
| 95 | Type I transferrin isoform profile (HP:0003642) | 1.62770475 |
| 96 | Palpitations (HP:0001962) | 1.62682186 |
| 97 | Abnormal protein glycosylation (HP:0012346) | 1.61829957 |
| 98 | Abnormal glycosylation (HP:0012345) | 1.61829957 |
| 99 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.61829957 |
| 100 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.61829957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.26229495 |
| 2 | NME2 | 5.17923059 |
| 3 | TESK2 | 4.15555301 |
| 4 | MAP4K2 | 3.96801589 |
| 5 | TESK1 | 3.80067436 |
| 6 | PHKG2 | 3.64613827 |
| 7 | PHKG1 | 3.64613827 |
| 8 | NUAK1 | 3.33388226 |
| 9 | LIMK1 | 3.25431836 |
| 10 | ARAF | 3.00190325 |
| 11 | LMTK2 | 2.80621847 |
| 12 | CASK | 2.45223688 |
| 13 | MOS | 2.18480210 |
| 14 | EIF2AK1 | 1.79921121 |
| 15 | TAF1 | 1.68890538 |
| 16 | BUB1 | 1.50035697 |
| 17 | CCNB1 | 1.49229522 |
| 18 | PIM2 | 1.47843942 |
| 19 | EPHA2 | 1.38076816 |
| 20 | CSNK1A1L | 1.33398209 |
| 21 | CSNK1G3 | 1.30121984 |
| 22 | ABL2 | 1.27879893 |
| 23 | OBSCN | 1.24153434 |
| 24 | BCKDK | 1.21204133 |
| 25 | CSNK1G1 | 1.19464388 |
| 26 | CSNK1G2 | 1.17282567 |
| 27 | RAF1 | 1.14973484 |
| 28 | NEK1 | 1.13087048 |
| 29 | LATS1 | 1.10734625 |
| 30 | TIE1 | 1.10311360 |
| 31 | TLK1 | 1.09668080 |
| 32 | VRK1 | 1.09415838 |
| 33 | TXK | 1.07041486 |
| 34 | DAPK1 | 0.95607991 |
| 35 | WNK4 | 0.89160211 |
| 36 | MAP3K9 | 0.87955346 |
| 37 | NEK9 | 0.87060780 |
| 38 | SRPK1 | 0.82193036 |
| 39 | EIF2AK3 | 0.81405193 |
| 40 | PBK | 0.81256495 |
| 41 | MAPKAPK3 | 0.81164430 |
| 42 | SMG1 | 0.80597851 |
| 43 | BRAF | 0.79793170 |
| 44 | AURKA | 0.78771260 |
| 45 | PTK2B | 0.76594015 |
| 46 | EIF2AK2 | 0.74999134 |
| 47 | MAP2K7 | 0.74071434 |
| 48 | STK16 | 0.73213758 |
| 49 | PRKD3 | 0.70088554 |
| 50 | GRK5 | 0.61685768 |
| 51 | MAP3K12 | 0.61103743 |
| 52 | MARK3 | 0.59216331 |
| 53 | TSSK6 | 0.56079744 |
| 54 | ILK | 0.50983957 |
| 55 | CHEK2 | 0.50109821 |
| 56 | TNIK | 0.47977754 |
| 57 | STK38L | 0.47204092 |
| 58 | HIPK2 | 0.44677540 |
| 59 | MAPK13 | 0.44134190 |
| 60 | STK38 | 0.40228354 |
| 61 | AKT3 | 0.39369459 |
| 62 | DYRK2 | 0.39226647 |
| 63 | MAPK7 | 0.38850469 |
| 64 | TRIM28 | 0.36898293 |
| 65 | MAPK11 | 0.35888022 |
| 66 | TAOK1 | 0.35644319 |
| 67 | KSR1 | 0.35172217 |
| 68 | PAK6 | 0.34629068 |
| 69 | PRKD2 | 0.33891683 |
| 70 | MAP3K13 | 0.31893531 |
| 71 | MST4 | 0.30793100 |
| 72 | PAK1 | 0.30720351 |
| 73 | PIM1 | 0.29958390 |
| 74 | MET | 0.29884194 |
| 75 | JAK3 | 0.29450001 |
| 76 | PLK3 | 0.28815236 |
| 77 | ERBB2 | 0.27535191 |
| 78 | CAMK2G | 0.25637197 |
| 79 | MARK1 | 0.25377989 |
| 80 | MINK1 | 0.25364497 |
| 81 | EPHA4 | 0.25157923 |
| 82 | EPHB2 | 0.25016758 |
| 83 | CSNK1A1 | 0.24578718 |
| 84 | ERBB4 | 0.23627777 |
| 85 | WNK1 | 0.23490404 |
| 86 | ATR | 0.22518308 |
| 87 | NTRK2 | 0.21440509 |
| 88 | MKNK2 | 0.21106056 |
| 89 | PRKCI | 0.21030860 |
| 90 | PIK3CA | 0.19470933 |
| 91 | INSRR | 0.19433482 |
| 92 | PDK2 | 0.18483258 |
| 93 | PRKCE | 0.16280422 |
| 94 | KDR | 0.14869186 |
| 95 | DYRK1A | 0.14172607 |
| 96 | CDK7 | 0.13919166 |
| 97 | PRKG1 | 0.13444886 |
| 98 | STK10 | 0.12565935 |
| 99 | TAOK2 | 0.12372604 |
| 100 | CSNK2A1 | 0.12311202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.19096219 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.98157054 |
| 3 | Circadian rhythm_Homo sapiens_hsa04710 | 2.60926743 |
| 4 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 2.52934607 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.47057984 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.46199571 |
| 7 | Salivary secretion_Homo sapiens_hsa04970 | 2.36003918 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.32017446 |
| 9 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.28169260 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.10185571 |
| 11 | Tight junction_Homo sapiens_hsa04530 | 2.01433391 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.97093639 |
| 13 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.93303102 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.91875290 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75101060 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.68331038 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.59942333 |
| 18 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.55829162 |
| 19 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.52867445 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.52793386 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.52215689 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.49355112 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46961981 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.37525728 |
| 25 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.32912852 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.31987684 |
| 27 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.31475107 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.29616159 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23384869 |
| 30 | Purine metabolism_Homo sapiens_hsa00230 | 1.22148353 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.22037186 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15845116 |
| 33 | Base excision repair_Homo sapiens_hsa03410 | 1.15438169 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.15019639 |
| 35 | RNA transport_Homo sapiens_hsa03013 | 1.11259534 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.09832325 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.07145936 |
| 38 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.05775624 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.05749107 |
| 40 | Homologous recombination_Homo sapiens_hsa03440 | 1.05506809 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03257831 |
| 42 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.03187416 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99418200 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98032559 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.96943150 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92084264 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91643110 |
| 48 | Morphine addiction_Homo sapiens_hsa05032 | 0.90043039 |
| 49 | Mineral absorption_Homo sapiens_hsa04978 | 0.89664503 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88267549 |
| 51 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.88064588 |
| 52 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83912070 |
| 53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81783616 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80890027 |
| 55 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.80431750 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80057839 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79503770 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79021642 |
| 59 | DNA replication_Homo sapiens_hsa03030 | 0.78019747 |
| 60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77694919 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73342491 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71929820 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71918382 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71900976 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71836717 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70599701 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68427109 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.68360131 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66636755 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63690452 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59595223 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59440974 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59328008 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58518040 |
| 75 | Nicotine addiction_Homo sapiens_hsa05033 | 0.58367528 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56758353 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56430702 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55743866 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55544087 |
| 80 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.54536389 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.54070967 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54015350 |
| 83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52362770 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48730702 |
| 85 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.46407413 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44586187 |
| 87 | Mismatch repair_Homo sapiens_hsa03430 | 0.43515431 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.42736498 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37305407 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.37019964 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37010663 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35476928 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35031383 |
| 94 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31675283 |
| 95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31310940 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31119258 |
| 97 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.29773425 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28961883 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27951182 |
| 100 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.26929497 |

